United States: October 2016 IPO Market Review

Last Updated: December 1 2016
Article by David Westenberg

The IPO market produced 19 IPOs in October, representing the highest monthly figure since the 33 IPOs in June 2015. Over the first ten months of 2016, there have been 88 IPOs—36% below the 138 IPOs over the corresponding period of 2015.

Buoyed by the largest IPO of the year, the $1.41 billion IPO by China's ZTO Express, gross proceeds for October were $4.57 billion, the highest monthly figure since October 2015. The first 10 months of 2016 have produced gross proceeds of $16.30 billion, 30% below the $23.34 billion raised over the first 10 months of 2015 and the third lowest annual tally over the past 12 years.

IPOs by emerging growth companies (EGCs) have accounted for 83% of the year's IPOs, down from 93% in 2015. Since enactment of the JOBS Act in 2012, 85% of all IPOs have been by EGCs.

October produced six IPOs by life sciences companies. Over the first 10 months of 2016, there have been 37 IPOs by life sciences companies, representing 42% of the year's total compared to 47% in 2015 and 40% in 2014. In absolute terms, however, the 2016 life sciences IPO count falls far short of the 98 life sciences IPOs in 2014 and 72 in 2015.

The median offering size for all IPOs over the first 10 months of 2016 was $94.5 million, or 3% above the $91.7 million for all IPOs in 2015, while the median offering size for life sciences company IPOs was $60.5 million, less than half of the $130.0 million figure for non-life sciences companies.

Year-to-date, the median offering size for IPOs by EGCs was $80.1 million, compared to $346.5 million for non-EGCs (the lowest annual figures since enactment of the JOBS Act). From 2012 to 2015, the median EGC IPO offering size was $87.0 million, compared to $425.5 million for non-EGCs.

The median annual revenue of IPO companies through the first 10 months of 2016 was $66.5 million, or 76% above the $37.8 million median figure for 2015, but well below the $92.7 million median figure for the five-year period from 2010 through 2014. The median life sciences IPO company in the first 10 months of 2016 had annual revenue of $4.0 million, compared to $214.3 million for all other IPO companies (the highest annual figure since 2009).

Only four IPO companies in October were profitable. Over the first 10 months of 2016, 35% of IPO companies have been profitable, compared to 30% in 2015 and 36% in 2014, but well below the 54% figure that prevailed over the five-year period preceding 2014. Excluding life sciences companies, 53% of IPO companies over the first 10 months of 2016 have been profitable, just shy of the 55% over the five-year period preceding 2016.

Following September, a month where all the month's new offerings posted a first-day gain, only 10 October IPOs posted a first-day gain. Two of the month's new offering were flat in first-day trading while the remaining seven were "broken" (IPOs whose stock closes below the offering price on their first day).

Through October 31, the average 2016 IPO has produced a first-day gain of 13%, compared to 16% in 2015 and the lowest annual figure since 2010. The average 2016 life sciences IPO company has gained 8% in first-day trading, compared to 17% for all other 2016 IPO companies.

Over the first 10 months of 2016, 24% of IPOs have been "broken". This figure is down from 26% in 2015 and 27% in 2014.

At October month-end, the average 2016 IPO company was trading 21% above its offering price. At October 31, 38% of 2016 IPO companies were trading below their offering price, while 35% were trading at least 25% above their offering price. The average 2016 life sciences company ended October up 19% from its offering price, while the average non-life sciences IPO company ended the month 23% above its offering price.

IPO activity in October consisted of offerings by the following companies listed in the order they came to market:

  • Advanced Disposal Services, a leading integrated provider of non-hazardous solid waste collection, transfer, recycling and disposal services operating primarily in secondary markets or under exclusive arrangements with municipalities, priced at the low end of the range and produced a first-day gain of 11%.
  • AquaVenture Holdings, a multinational provider of Water-as-a-Service solutions that provides its customers with a reliable and cost-effective source of clean drinking and process water primarily under long-term contracts that minimize capital investment by the customer, priced at the low end of the range and ended its first day of trading up 22% from its offering price.
  • Coupa Software, the leading provider of a unified, cloud-based spend management platform that connects more than 460 organizations with more than two million suppliers globally, priced an upsized IPO at the high end of an upwardly revised price range and gained 85% in first-day trading—the third best first-day gain of the year.
  • Obalon Therapeutics, a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss, priced within the range and was flat in first-day trading.
  • Camping World Holdings, a provider of a comprehensive portfolio of services, protection plans, products and resources for recreational vehicle enthusiasts, priced at the midpoint of the range and produced a 2% first-day gain.
  • Everspin Technologies, the leading provider of MRAM solutions that offer the persistence of non-volatile memory, a type of memory that retains information even in the absence of power, with the speed and endurance of random access memory (RAM), and enables the protection of mission critical data particularly in the event of power interruption or failure, priced an upsized IPO below the range and eked out a two cent gain in first-day trading.
  • Azure Power Global, a seller of solar power in India on long-term fixed price contracts to its customers, at prices which in many cases are at or below prevailing alternatives for these customers, priced below the range and ended its first day of trading down 19% from its offering price.
  • AzurRx BioPharma, a company engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders, priced a downsized IPO below the original range and ended its first trading day down less than 1% from its offering price.
  • Extraction Oil & Gas, an independent oil and gas company focused on the acquisition, development and production of oil, natural gas and natural gas liquid reserves in the Rocky Mountains, primarily in the Wattenberg Field of the Denver-Julesburg Basin of Colorado, priced above the range and gained 15% on its first day of trading.
  • Mammoth Energy Services, an integrated, growth-oriented oilfield service company serving companies engaged in the exploration and development of North American onshore unconventional oil and natural gas reserves, priced at the low end of the range and declined 12% in first-day trading.
  • CRISPR Therapeutics, a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics, priced below the range and ended its first day of trading with a gain of less than 1%.
  • Forterra, a leading manufacturer of pipe and precast products by sales volume in the United States and Eastern Canada for a variety of water-related infrastructure applications, including water transmission, distribution and drainage, priced below the range and ended its first trading day down 8% from its offering price.
  • iRhythm Technologies, a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining its wearable biosensing technology with cloud-based data analytics and machine-learning capabilities, priced an upsized IPO above the range and produced a 53% first-day gain.
  • Ra Pharmaceuticals, a clinical-stage biopharmaceutical company using its proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, priced an upsized IPOs at the midpoint of the range and was flat in first-day trading.
  • Myovant Sciences, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders, priced an upsized IPO above the range and ended its first day of trading 12% below its offering price.
  • ZTO Express, a leading express delivery company in China and one of the largest express delivery companies globally, in terms of total parcel volume in 2015, priced above the range and declined 15% in first-day trading.
  • Acushnet Holdings, a global leader in the design, development, manufacture and distribution of performance-driven golf products, priced below the range and produced a 6% first-day gain.
  • BlackLine, a creator of a comprehensive cloud-based software platform designed to transform and modernize accounting and finance operations for organizations of all types and sizes, priced at the high end of an upwardly revised price range and ended its first day of trading 39% above its offering price.
  • Quantenna Communications, a leader in the design, development and marketing of advanced high-speed wireless communication solutions enabling wireless local area networking, priced at the high end of the range and ended its first trading day down 3% from its offering price.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
WilmerHale
WilmerHale
WilmerHale
WilmerHale
WilmerHale
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
WilmerHale
WilmerHale
WilmerHale
WilmerHale
WilmerHale
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions